TY - JOUR AU - Sockel, Katja AU - Platzbecker, Uwe PY - 2013 TI - Is it already time for combination treatment in lower risk MDS? JF - Chinese Clinical Oncology; Vol 1, No 2 (December 01, 2012): Chinese Clinical Oncology Y2 - 2013 KW - N2 - The term myelodysplastic syndrome (MDS) summarizes a range of different hematological disorders, which display peripheral cytopenias as common clinical characteristic. This “ineffective hematopoiesis” is thought to be a result of an imbalance of apoptotic and proliferative signals in bone marrow cells (1). UR - https://cco.amegroups.org/article/view/1351